Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Osteoporosis Drugs
The 2025-2030 World Outlook for Osteoporosis Drugs This study covers the world outlook for osteoporosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Drugs
The 2025-2030 World Outlook for Colorectal Cancer Drugs This study covers the world outlook for colorectal cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatments This study covers the world outlook for alpha-1 antitrypsin deficiency treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Orphan Cancer Drugs
The 2025-2030 World Outlook for Orphan Cancer Drugs This study covers the world outlook for orphan cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Tumors
The 2025-2030 World Outlook for Neuroendocrine Tumors This study covers the world outlook for neuroendocrine tumors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for CNS Therapeutics
The 2025-2030 World Outlook for CNS Therapeutics This study covers the world outlook for CNS therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Alopecia Drugs
The 2025-2030 World Outlook for Alopecia Drugs This study covers the world outlook for alopecia drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2025-2030 World Outlook for Melanoma Therapeutics
The 2025-2030 World Outlook for Melanoma Therapeutics This study covers the world outlook for melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments
The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments This study covers the world outlook for disease-specific chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More
-
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics This study covers the world outlook for non-small cell lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments
The 2025-2030 World Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments This study covers the world outlook for IBD (ulcerative colitis and Crohn's disease) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics
The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics This study covers the world outlook for aldosterone-antagonist dilated cardiomyopathy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potentia ... Read More
-
The 2025-2030 World Outlook for Prostaglandin Glaucoma Therapeutics
The 2025-2030 World Outlook for Prostaglandin Glaucoma Therapeutics This study covers the world outlook for prostaglandin glaucoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Hepatitis Therapeutics
The 2025-2030 World Outlook for Hepatitis Therapeutics This study covers the world outlook for hepatitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Exosome Therapeutics
The 2025-2030 World Outlook for Exosome Therapeutics This study covers the world outlook for exosome therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Small Molecule Drug Discovery Technologies
The 2025-2030 World Outlook for Small Molecule Drug Discovery Technologies This study covers the world outlook for small molecule drug discovery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments
The 2025-2030 World Outlook for Anti-Rejection Drugs and Immunosuppressants for Liver Diseases Treatments This study covers the world outlook for anti-rejection drugs and immunosuppressants for liver diseases treatments across more than 190 countries. For each year reported, estimates are given for ... Read More
-
The 2025-2030 World Outlook for Inflammatory Bowel Disease Treatments
The 2025-2030 World Outlook for Inflammatory Bowel Disease Treatments This study covers the world outlook for inflammatory bowel disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics This study covers the world outlook for multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics This study covers the world outlook for colorectal cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Oncology Small Molecule Drug Discovery
The 2025-2030 World Outlook for Oncology Small Molecule Drug Discovery This study covers the world outlook for oncology small molecule drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Immunoglobulin Plasma Therapeutics
The 2025-2030 World Outlook for Immunoglobulin Plasma Therapeutics This study covers the world outlook for immunoglobulin plasma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Therapeutics Proteins
The 2025-2030 World Outlook for Therapeutics Proteins This study covers the world outlook for therapeutics proteins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Neurtrophic Keratitis
The 2025-2030 World Outlook for Neurtrophic Keratitis This study covers the world outlook for neurtrophic keratitis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Neuroprotective Agents
The 2025-2030 World Outlook for Neuroprotective Agents This study covers the world outlook for neuroprotective agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
Research Assistance
